Whiz Partners Inc.

Whiz Partners Inc.

2021

Whiz Partners Established a New Company to Generate Composition of Matter Patents for New Chemical Entities and Contribute to the R&D of Pharmaceutical Companies

News Release from Whiz Partners Read the rest of this entry »

Establishment of Healthcare New Platform Fund Limited Partnership

News Release from Whiz Partners Read the rest of this entry »

Whiz Partners Announces Appointment of COO and CIO as Members of the Board

News Release from Whiz Partners Read the rest of this entry »

Axcelead Decided to Build an mRNA Drug Manufacturing Plant in Minamisoma City, Fukushima Prefecture

  • 05-27-2021
  • Categories: 2021

News Release from Axcelead Read the rest of this entry »

Axcelead Launches ARCALIS, a Joint Venture to Manufacture mRNA Therapeutics

News Release from Axcelead Read the rest of this entry »

Notice of the Execution of a Contract with the Japan Agency for Medical Research and Development NanoCarrier and Axcelead Establish PrimRNA, a New Company Involved in the Development of mRNA Therapeutics

News Release from NanoCarrier and Axcelead Read the rest of this entry »

Axcelead’s partner company – AXEL MARK announces the press release about business alliance with Ascella Biosystems

News Release from AXEL MARK Read the rest of this entry »

AXEL MARK and Axcelead have Agreed to Cooperate in Product Evaluation & Domestic Logistics of Molecular Diagnostics Field

News Release from AXEL MARK and Axcelead Read the rest of this entry »

Hitachi and Axcelead have agreed to start joint development of solutions contributing on more efficient creation of next-generation biopharmaceuticals

News Release from Axcelead Drug Discovery Partners Inc. Read the rest of this entry »

News Release about Final Closing of Drug Discovery Gateway Fund (LP)

Please refer to the press release for further detail. Read the rest of this entry »

PAGE TOP